Cargando…
A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia
In this study, we determine and compare the incubation duration, serial interval, pre-symptomatic transmission, and case fatality rate of MERS-CoV and COVID-19 in Saudi Arabia based on contact tracing data we acquired in Saudi Arabia. The date of infection and infector-infectee pairings are deduced...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343745/ https://www.ncbi.nlm.nih.gov/pubmed/35938094 http://dx.doi.org/10.1016/j.idm.2022.07.002 |
_version_ | 1784761057701527552 |
---|---|
author | Althobaity, Yehya Wu, Jianhong Tildesley, Michael J. |
author_facet | Althobaity, Yehya Wu, Jianhong Tildesley, Michael J. |
author_sort | Althobaity, Yehya |
collection | PubMed |
description | In this study, we determine and compare the incubation duration, serial interval, pre-symptomatic transmission, and case fatality rate of MERS-CoV and COVID-19 in Saudi Arabia based on contact tracing data we acquired in Saudi Arabia. The date of infection and infector-infectee pairings are deduced from travel history to Saudi Arabia or exposure to confirmed cases. The incubation times and serial intervals are estimated using parametric models accounting for exposure interval censoring. Our estimations show that MERS-CoV has a mean incubation time of 7.21 (95% CI: 6.59–7.85) days, whereas COVID-19 (for the circulating strain in the study period) has a mean incubation period of 5.43(95% CI: 4.81–6.11) days. MERS-CoV has an estimated serial interval of 14.13(95% CI: 13.9–14.7) days, while COVID-19 has an estimated serial interval of 5.1(95% CI: 5.0–5.5) days. The COVID-19 serial interval is found to be shorter than the incubation time, indicating that pre-symptomatic transmission may occur in a significant fraction of transmission events. We conclude that during the COVID-19 wave studied, at least 75% of transmission happened prior to the onset of symptoms. The CFR for MERS-CoV is estimated to be 38.1% (95% CI: 36.8–39.5), while the CFR for COVID-19 1.67% (95% CI: 1.63–1.71). This work is expected to help design future surveillance and intervention program targeted at specific respiratory virus outbreaks, and have implications for contingency planning for future coronavirus outbreaks. |
format | Online Article Text |
id | pubmed-9343745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | KeAi Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-93437452022-08-02 A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia Althobaity, Yehya Wu, Jianhong Tildesley, Michael J. Infect Dis Model Article In this study, we determine and compare the incubation duration, serial interval, pre-symptomatic transmission, and case fatality rate of MERS-CoV and COVID-19 in Saudi Arabia based on contact tracing data we acquired in Saudi Arabia. The date of infection and infector-infectee pairings are deduced from travel history to Saudi Arabia or exposure to confirmed cases. The incubation times and serial intervals are estimated using parametric models accounting for exposure interval censoring. Our estimations show that MERS-CoV has a mean incubation time of 7.21 (95% CI: 6.59–7.85) days, whereas COVID-19 (for the circulating strain in the study period) has a mean incubation period of 5.43(95% CI: 4.81–6.11) days. MERS-CoV has an estimated serial interval of 14.13(95% CI: 13.9–14.7) days, while COVID-19 has an estimated serial interval of 5.1(95% CI: 5.0–5.5) days. The COVID-19 serial interval is found to be shorter than the incubation time, indicating that pre-symptomatic transmission may occur in a significant fraction of transmission events. We conclude that during the COVID-19 wave studied, at least 75% of transmission happened prior to the onset of symptoms. The CFR for MERS-CoV is estimated to be 38.1% (95% CI: 36.8–39.5), while the CFR for COVID-19 1.67% (95% CI: 1.63–1.71). This work is expected to help design future surveillance and intervention program targeted at specific respiratory virus outbreaks, and have implications for contingency planning for future coronavirus outbreaks. KeAi Publishing 2022-08-02 /pmc/articles/PMC9343745/ /pubmed/35938094 http://dx.doi.org/10.1016/j.idm.2022.07.002 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Althobaity, Yehya Wu, Jianhong Tildesley, Michael J. A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia |
title | A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia |
title_full | A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia |
title_fullStr | A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia |
title_full_unstemmed | A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia |
title_short | A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia |
title_sort | comparative analysis of epidemiological characteristics of mers-cov and sars-cov-2 in saudi arabia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343745/ https://www.ncbi.nlm.nih.gov/pubmed/35938094 http://dx.doi.org/10.1016/j.idm.2022.07.002 |
work_keys_str_mv | AT althobaityyehya acomparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia AT wujianhong acomparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia AT tildesleymichaelj acomparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia AT althobaityyehya comparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia AT wujianhong comparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia AT tildesleymichaelj comparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia |